⚠ Tool for educational and informational purposes only — not investment advice or a recommendation to buy or sell. Investing carries risk of capital loss. Read the full disclaimer.
CTVA — Vylor, Inc.
Last scan (Oct. 2, 2026): price $12.57, RSI 5.82, relative volume 18.47x, MACD ⚪ No, score 60.00.
It's trading below its 200-day average, with an RSI of 5.82 in oversold territory — technically weak, though that can also signal the pessimism is already priced in. Neither the MACD nor a range breakout gives a technical entry signal right now. Today's volume is 18.47x average — well above normal activity, a sign of real interest. The analysts' average target price implies +636.7% upside — one of the score's strongest signals. Today it holds rank #2 in the Medium group on Smart Scanner's upside + relative volume ranking.
Price chart
CTVA
Price: $12.99 · RSI (14): 26.42 · Rel. volume: 1.27x · Breakout: No
- Current price: ($12.99) — solid white line — the latest available closing price.
- Target price: ($92.6) — dashed green line — average 12-month target price from analysts covering the stock.
- Quarter low: ($11.84) — dotted orange line — the lowest price over the last ~3 months, as a recent support reference.
You can zoom by dragging a rectangle over the chart, or with your mouse wheel. Double-click to reset the view.
What analysts say
CTVA
Vylor, Inc.
Corteva, Inc. operates as a pure-play agriculture company. The company offers products that protect against weeds, insects and other pests, and disease, as well as supports crop health via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers tools to…
- Buy 15
- Hold 6
- Sell 0
Average target price: $92.6 (+612.6% vs. current price) · range $78.0 – $103.0
Healthy Moderate Attention No data
Total market value of the company (price × shares outstanding).
?
P/E (trailing): compares the stock's price with its earnings per share over the last 12 months — how many times that earning is being paid for.
Low: the market pays little for each dollar of earnings. Could be a value opportunity, or a sign the market expects little growth.
?
P/E (forward): same as P/E, but using analysts' estimated earnings per share for the next year.
Same as P/E, using estimated future earnings.
?
PEG: the P/E divided by the expected earnings growth rate — relates how expensive the stock is to how fast it's expected to grow.
Between 1 and 2: the price is roughly aligned with expected growth.
?
Debt/Equity: how much debt the company carries per dollar of shareholder equity — measures how leveraged the balance sheet is.
Not enough data.
?
Net margin: what percentage of each dollar of revenue ends up as net profit, after all costs.
Low margin: the business has little cushion if costs rise.
?
Dividend: what percentage of the stock's price is paid out in cash to shareholders each year.
Pays out a portion of its earnings as cash to shareholders on a recurring basis.
?
Beta: how volatile the stock is compared to the overall market (S&P 500 = 1.0).
Not enough data.
General reference ranges, do not vary by sector. Third-party data; may be incomplete. Not investment advice.
💰 Financial Statements (last 3 quarters)
💰 Financial Statements (last 3 quarters)
What this chart shows
- Japanese candlesticks: green when the period's close is higher than its open, red when it's lower.
- Volume: bars colored the same as the candle for that period.
- RSI (14): bottom line with reference levels at 70 (overbought) and 30 (oversold) — the same indicator the daily scanner uses.
- Dotted line on top: the high of the last 20 periods, the same reference the scanner uses to detect breakouts.
Third-party market data, for informational purposes. Not investment advice — read the disclaimer.